Peptide ligand-mediated endocytosis of nanoparticles to cancer cells: Cell receptor-binding- versus cell membrane-penetrating peptides

Eunji Jo, June Seok Heo, Ja Yun Lim, Bo Ram Lee, Chul Joo Yoon, Jinkwan Kim, Jeewon Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The endocytosis-mediating performances of two types of peptide ligands, cell receptor binding peptide (CRBP) and cell membrane penetrating peptide (CMPP), were analyzed and compared using a common carrier of peptide ligands-human ferritin heavy chain (hFTH) nanoparticle. Twenty-four copies of a CMPP(human immunodeficiency virus-derived TAT peptide) and/or a CRBP (peptide ligand with strong and specific affinity for either human integrin(αvβ3) or epidermal growth factor receptor I (EGFR) that is overexpressed on various cancer cells) were genetically presented on the surface of each hFTH nanopariticle. The quantitative level of endocytosis and intracellular localization of fluorescence dye-labeled CRBP- and CMPP-presenting nanoparticles were estimated in the in vitro cultures of integrin- and EGFR-overexpressing cancer and human dermal fibroblast cells(control). From the cancer cell cultures treated with the CMPP- and CRBP-presenting nanoparticles, it was notable that CRBPs resulted in quantitatively higher level of endocytosis than CMPP (TAT) and successfully transported the nanoparticles to the cytosol of cancer cells depending on concentration and treatment period of time, whereas TAT-mediated endocytosis localized most of the nanoparticles within endosomal vesicles under the same conditions. These novel findings provide highly useful informations to many researchers both in academia and in industry who are interested in developing anticancer drug delivery systems/carriers.

Original languageEnglish
Pages (from-to)1437-1449
Number of pages13
JournalBiotechnology and Bioengineering
Volume115
Issue number6
DOIs
Publication statusPublished - 2018 Jun 1

Fingerprint

Cell-Penetrating Peptides
Cell membranes
Endocytosis
Nanoparticles
Peptides
Ligands
Cells
Cell Membrane
Peptide Receptors
Neoplasms
Apoferritins
Epidermal Growth Factor Receptor
Integrins
Skin Neoplasms
Drug Delivery Systems
Cytosol
Industry
Coloring Agents
Cell Culture Techniques
Fibroblasts

Keywords

  • cancer cell membrane-penetrating peptide
  • cancer cell receptor-binding peptide
  • cancer targeting
  • peptide ligand-mediated endocytosis
  • protein nanoparticle carrier

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Peptide ligand-mediated endocytosis of nanoparticles to cancer cells : Cell receptor-binding- versus cell membrane-penetrating peptides. / Jo, Eunji; Heo, June Seok; Lim, Ja Yun; Lee, Bo Ram; Yoon, Chul Joo; Kim, Jinkwan; Lee, Jeewon.

In: Biotechnology and Bioengineering, Vol. 115, No. 6, 01.06.2018, p. 1437-1449.

Research output: Contribution to journalArticle

Jo, Eunji ; Heo, June Seok ; Lim, Ja Yun ; Lee, Bo Ram ; Yoon, Chul Joo ; Kim, Jinkwan ; Lee, Jeewon. / Peptide ligand-mediated endocytosis of nanoparticles to cancer cells : Cell receptor-binding- versus cell membrane-penetrating peptides. In: Biotechnology and Bioengineering. 2018 ; Vol. 115, No. 6. pp. 1437-1449.
@article{16a0827071394ecdbde57dc4c39fdba0,
title = "Peptide ligand-mediated endocytosis of nanoparticles to cancer cells: Cell receptor-binding- versus cell membrane-penetrating peptides",
abstract = "The endocytosis-mediating performances of two types of peptide ligands, cell receptor binding peptide (CRBP) and cell membrane penetrating peptide (CMPP), were analyzed and compared using a common carrier of peptide ligands-human ferritin heavy chain (hFTH) nanoparticle. Twenty-four copies of a CMPP(human immunodeficiency virus-derived TAT peptide) and/or a CRBP (peptide ligand with strong and specific affinity for either human integrin(αvβ3) or epidermal growth factor receptor I (EGFR) that is overexpressed on various cancer cells) were genetically presented on the surface of each hFTH nanopariticle. The quantitative level of endocytosis and intracellular localization of fluorescence dye-labeled CRBP- and CMPP-presenting nanoparticles were estimated in the in vitro cultures of integrin- and EGFR-overexpressing cancer and human dermal fibroblast cells(control). From the cancer cell cultures treated with the CMPP- and CRBP-presenting nanoparticles, it was notable that CRBPs resulted in quantitatively higher level of endocytosis than CMPP (TAT) and successfully transported the nanoparticles to the cytosol of cancer cells depending on concentration and treatment period of time, whereas TAT-mediated endocytosis localized most of the nanoparticles within endosomal vesicles under the same conditions. These novel findings provide highly useful informations to many researchers both in academia and in industry who are interested in developing anticancer drug delivery systems/carriers.",
keywords = "cancer cell membrane-penetrating peptide, cancer cell receptor-binding peptide, cancer targeting, peptide ligand-mediated endocytosis, protein nanoparticle carrier",
author = "Eunji Jo and Heo, {June Seok} and Lim, {Ja Yun} and Lee, {Bo Ram} and Yoon, {Chul Joo} and Jinkwan Kim and Jeewon Lee",
year = "2018",
month = "6",
day = "1",
doi = "10.1002/bit.26575",
language = "English",
volume = "115",
pages = "1437--1449",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Peptide ligand-mediated endocytosis of nanoparticles to cancer cells

T2 - Cell receptor-binding- versus cell membrane-penetrating peptides

AU - Jo, Eunji

AU - Heo, June Seok

AU - Lim, Ja Yun

AU - Lee, Bo Ram

AU - Yoon, Chul Joo

AU - Kim, Jinkwan

AU - Lee, Jeewon

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The endocytosis-mediating performances of two types of peptide ligands, cell receptor binding peptide (CRBP) and cell membrane penetrating peptide (CMPP), were analyzed and compared using a common carrier of peptide ligands-human ferritin heavy chain (hFTH) nanoparticle. Twenty-four copies of a CMPP(human immunodeficiency virus-derived TAT peptide) and/or a CRBP (peptide ligand with strong and specific affinity for either human integrin(αvβ3) or epidermal growth factor receptor I (EGFR) that is overexpressed on various cancer cells) were genetically presented on the surface of each hFTH nanopariticle. The quantitative level of endocytosis and intracellular localization of fluorescence dye-labeled CRBP- and CMPP-presenting nanoparticles were estimated in the in vitro cultures of integrin- and EGFR-overexpressing cancer and human dermal fibroblast cells(control). From the cancer cell cultures treated with the CMPP- and CRBP-presenting nanoparticles, it was notable that CRBPs resulted in quantitatively higher level of endocytosis than CMPP (TAT) and successfully transported the nanoparticles to the cytosol of cancer cells depending on concentration and treatment period of time, whereas TAT-mediated endocytosis localized most of the nanoparticles within endosomal vesicles under the same conditions. These novel findings provide highly useful informations to many researchers both in academia and in industry who are interested in developing anticancer drug delivery systems/carriers.

AB - The endocytosis-mediating performances of two types of peptide ligands, cell receptor binding peptide (CRBP) and cell membrane penetrating peptide (CMPP), were analyzed and compared using a common carrier of peptide ligands-human ferritin heavy chain (hFTH) nanoparticle. Twenty-four copies of a CMPP(human immunodeficiency virus-derived TAT peptide) and/or a CRBP (peptide ligand with strong and specific affinity for either human integrin(αvβ3) or epidermal growth factor receptor I (EGFR) that is overexpressed on various cancer cells) were genetically presented on the surface of each hFTH nanopariticle. The quantitative level of endocytosis and intracellular localization of fluorescence dye-labeled CRBP- and CMPP-presenting nanoparticles were estimated in the in vitro cultures of integrin- and EGFR-overexpressing cancer and human dermal fibroblast cells(control). From the cancer cell cultures treated with the CMPP- and CRBP-presenting nanoparticles, it was notable that CRBPs resulted in quantitatively higher level of endocytosis than CMPP (TAT) and successfully transported the nanoparticles to the cytosol of cancer cells depending on concentration and treatment period of time, whereas TAT-mediated endocytosis localized most of the nanoparticles within endosomal vesicles under the same conditions. These novel findings provide highly useful informations to many researchers both in academia and in industry who are interested in developing anticancer drug delivery systems/carriers.

KW - cancer cell membrane-penetrating peptide

KW - cancer cell receptor-binding peptide

KW - cancer targeting

KW - peptide ligand-mediated endocytosis

KW - protein nanoparticle carrier

UR - http://www.scopus.com/inward/record.url?scp=85043247064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043247064&partnerID=8YFLogxK

U2 - 10.1002/bit.26575

DO - 10.1002/bit.26575

M3 - Article

C2 - 29460954

AN - SCOPUS:85043247064

VL - 115

SP - 1437

EP - 1449

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 6

ER -